Invesco Comstock Contrarian Equity ETF (BATS:CSTK – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totaling 7,217 shares, a growth of 83.2% from the September 30th total of 3,939 shares. Based on an average daily trading volume, of 19,916 shares, the short-interest ratio is presently 0.4 days. Currently, 0.2% of the shares of the company are sold short.
Invesco Comstock Contrarian Equity ETF Stock Performance
Shares of BATS CSTK opened at $33.31 on Tuesday. The company has a market capitalization of $131.24 million and a PE ratio of 17.05. The company’s fifty day moving average price is $33.34 and its 200 day moving average price is $31.91. Invesco Comstock Contrarian Equity ETF has a 1 year low of $27.42 and a 1 year high of $34.33.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Invesco Comstock Contrarian Equity ETF stock. Commonwealth Equity Services LLC bought a new position in shares of Invesco Comstock Contrarian Equity ETF (BATS:CSTK – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 7,912 shares of the company’s stock, valued at approximately $257,000. Commonwealth Equity Services LLC owned approximately 0.20% of Invesco Comstock Contrarian Equity ETF as of its most recent SEC filing.
Invesco Comstock Contrarian Equity ETF Company Profile
Invesco Actively Managed Exchange Traded Fund Trust – Invesco Comstock Contrarian Equity ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. The fund is co-managed by Invesco Advisers, Inc The fund invests in the equity markets. The fund invests directly and through derivatives in stocks of companies across diversified sectors. It invests in value stocks of large-cap companies. Invesco Actively Managed Exchange Traded Fund Trust – Invesco Comstock Contrarian Equity ETF is domiciled in the United States.
See Also
- Five stocks we like better than Invesco Comstock Contrarian Equity ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Invesco Comstock Contrarian Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Comstock Contrarian Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
